Rivaroxaban CAS 366789-02-8 Purity >99,5% (HPLC) Pabrik API Kualitas Luhur
Produsén Pasokan Rivaroxaban Patali Panganteur:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-hiji CAS 438056-69-0
Rivaroxaban panengah CAS 446292-07-5
5-Clorothiophene-2-Asam Karboksilat CAS 24065-33-6
5-Klorotiofén-2-Karbonil Klorida CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8
Ngaran Kimia | Rivaroxaban |
sinonim | (S) -Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3- (4- (3-oxomorpholino) phenyl) -oxazolidin-5-yl) métil) thiophene-2-carbox;teluk 59-7939 |
Nomer CAS | 366789-02-8 |
Status Saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C19H18ClN3O5S |
Beurat Molekul | 435.88 |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bubuk Bodas atanapi Méh Bodas |
Idéntifikasi A | Nyerep infra red Rivaroxaban saluyu sareng standar rujukan |
Idéntifikasi B | Waktu ingetan tina puncak utama leyuran sampel pakait jeung nu sahiji solusi suitability sistem, sakumaha diala dina purity enantiomeric. |
Enantiomeric Purity | RVX RC01: ≤0,15% |
Kelembapan (KF) | ≤0,50% |
Abu Sulfat | ≤0,10% |
Logam beurat | ≤20ppm |
Asam asétat | ≤5000ppm |
Bahan Patali (HPLC) | |
RVX RC02 | ≤0,15% |
RVX RC03 | ≤0,15% |
RVX RC04 | ≤0,15% |
RVX RC05 | ≤0,15% |
RVX RC06 | ≤0,15% |
RVX RC07 | ≤0,15% |
RVX RC08 | ≤0,15% |
Sagala Najis Pribadi lianna | ≤0,10% |
Total Kotoran | <0,50% |
Sésa pangleyur (GC) | |
Étanol | ≤5000ppm |
Toluén | ≤890ppm |
Triétilamin | ≤320ppm |
Kamurnian / Métode Analisis | > 99,5% (HPLC) (dina dasar anhidrat) |
Standar tés | Standar Perusahaan |
Pamakéan | API;Ubar Antitrombotik;Inhibitor FXa |
Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) mangrupikeun antikoagulan oral.Ieu mangrupakeun oral aktif langsung faktor Xa inhibitor.Rivaroxaban dituduhkeun pikeun 'perlakuan thrombosis urat jero sareng embolisme pulmonal, sareng pencegahan trombosis urat jero kambuh sareng embolisme pulmonal di déwasa'.Pikeun pengobatan awal embolisme pulmonal akut, dosis anu disarankeun tina rivaroxaban nyaéta 15 mg dua kali sadinten pikeun 21 dinten kahiji dituturkeun ku 20 mg sakali sadinten pikeun pengobatan terus-terusan sareng pencegahan tromboembolisme vena anu kambuh.Non-Valvular Atrial Fibrillation (NVAF) pikeun nyegah stroke & embolisme sistemik.Perawatan VTE akut & pencegahan VTE kambuh [pikeun trombosis urat jero (DVT) sareng embolisme pulmonal (PE)].Pencegahan kajadian thromboembolic vena (VTE) dina elective total hip atawa bedah ngagantian dengkul (THR, TKR).
-
Rivaroxaban CAS 366789-02-8 Purity >99,5% (HPLC...
-
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Pu...
-
4-(4-Aminophenyl)morpholin-3-Hiji CAS 438056-69-...
-
Rivaroxaban panengah CAS 446292-07-5 Purity...
-
5-Clorothiophene-2-Asam Karboksilat CAS 24065-3...
-
5-Klorothiofen-2-Karbonil Klorida CAS 42518...
-
4,5-Dichlorothiophene-2-Asam Karboksilat CAS 311...